Found 6 matching trials
A Follow-up Evaluation Study of PRI-724-1101
N/AThe purpose of this study To evaluate the safety and efficacy of PRI-724 ad...
Location
Tokyo metropolitan Komagome Hospital
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
PHASE1To evaluate the safety and pharmacokinetics of OP-724 and to determine the ...
Location
Tokyo Metropolitan Komagome Hospital
An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis
PHASE1The purpose of this study is to investigate the safety and tolerability of ...
Location
Tokyo metropolitan Komagome Hospital
A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)
PHASE2This is a phase 2 trial of foscenvivint in liver cirrhosis patients caused ...
Location
Hokkaido University Hospital
A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
PHASE2This is a phase 2 study to evaluate the efficacy and safety of foscenvivint...
Location
Hokkaido University Hospital
Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.
PHASE1To evaluate the safety and tolerability of OP-724 in liver cirrhosis patien...
Location
Tokyo Metropolitan Komagome Hospital